Document is current
Any future updates will be listed below
-
Authors
Campagnolo, M. https://orcid.org/0000-0002-6394-7168
Puthenparampil, M.
Emmi, A.
Weis, L.
Basili, E.
Mauceri, V.
Miscioscia, A.
Carecchio, M.
Guerra, A.
Misenti, V.
Fogliano, C.
Gallo, P.
Antonini, A.
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 25 March 2025
First Online: 15 April 2025
Declarations
:
: The authors declare no disclosures or conflicts of interest related to the manuscript's content. AA has received compensation for consultancy and speaker related activities from UCB, Bayer, Ever Pharma, Britannia, AbbVie, Zambon, Bial, Theravance Biopharma, Jazz Pharmaceuticals, Roche, Medscape; he receives research support from Horizon 2020, Italian Ministry of University and Research (MUR), Italian Ministry of Health, Next Generation EU—National Center for Gene Therapy and Drugs based on RNA Technology and National Recovery and Resilience Plan, Investment PE8 – Project Age-It: “Ageing Well in an Ageing Society”.MC has received travel grants from Zambon and receives support from Progetto di ricerca di Rilevante Interesse Nazionale – PRIN 2022 FJAXY8. All the other authors have no financial disclosure to declare.
: Written informed consent was obtained from each participant after a detailed description of the study. Informed consent for the use of biological samples was obtained from all patients. All procedures on human tissue samples were carried out in accordance with the Declaration of Helsinki.
